Clinical Trial Update: Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial in Japanese patients with advanced solid malignancies or non-small cell lung cancer evaluated the safety and tolerability of AZD6244 (selumetini…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• AZD6244 (selumetinib)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: AstraZeneca | Conditions: Neoplasms,, Metastatic Cancer, | Phase 1 | Status: COMPLETED | Results posted: 2016-07-14